{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:16:24Z","timestamp":1782407784961,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015083","name":"Peking University People's Hospital","doi-asserted-by":"publisher","award":["RDL2023-04"],"award-info":[{"award-number":["RDL2023-04"]}],"id":[{"id":"10.13039\/501100015083","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaad.2025.09.055","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:20:47Z","timestamp":1758576047000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real-world effectiveness and safety of oral Janus kinase inhibitor in vitiligo: A retrospective study"],"prefix":"10.1016","author":[{"given":"Xiaoyi","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongsi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2025.09.055_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.09.055_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12951-025-03119-1","article-title":"Biomimetic polydopamine loaded with janus kinase inhibitor for synergistic vitiligo therapy via hydrogel microneedles","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.jaad.2025.09.055_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cytogfr.2024.11.002","article-title":"JAK inhibitors in immune regulation and treatment of vitiligo","volume":"80","author":"Liu","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"10.1016\/j.jaad.2025.09.055_bib4","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1111\/jdv.20109","article-title":"Oral tofacitinib, baricitinib and upadacitinib monotherapy for steroid-resistant vitiligo: a prospective case series","volume":"39","author":"Zhu","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2025.09.055_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jaad.2024.05.078","article-title":"A prospective observational study of oral abrocitinib and narrow-band ultraviolet-B in refractory progressive vitiligo","volume":"91","author":"Xu","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.09.055_bib6","first-page":"639","article-title":"Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: a randomized phase 2b clinical trial","volume":"89","author":"Ezzedine","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.09.055_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790125","article-title":"Janus kinase inhibitors in the treatment of vitiligo: a review","volume":"12","author":"Qi","year":"2021","journal-title":"Front Immunol"},{"issue":"49","key":"10.1016\/j.jaad.2025.09.055_bib8","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1038\/sj.onc.1203925","article-title":"Janus kinases: components of multiple signaling pathways","volume":"19","author":"Rane","year":"2000","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.jaad.2025.09.055_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.abd.2023.03.001","article-title":"JAK-STAT pathway inhibitors in dermatology","volume":"98","author":"Miot","year":"2023","journal-title":"Bras Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.09.055_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamadermatol.2024.5737","article-title":"Combination of baricitinib and phototherapy in adults with active vitiligo: a randomized clinical trial","volume":"161","author":"Seneschal","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.09.055_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00403-025-04151-9","article-title":"A retrospective analysis of the efficacy and safety of oral tofacitinib in active vitiligo treatment","volume":"317","author":"Hu","year":"2025","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"10.1016\/j.jaad.2025.09.055_bib12","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jaad.2023.07.1016","article-title":"Efficacy and tolerability of oral upadacitinib monotherapy in patients with recalcitrant vitiligo","volume":"89","author":"Su","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.09.055_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00403-024-03658-x","article-title":"Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series","volume":"317","author":"Zhu","year":"2024","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"10.1016\/j.jaad.2025.09.055_bib14","doi-asserted-by":"crossref","first-page":"2492879","DOI":"10.1080\/09546634.2025.2492879","article-title":"Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib","volume":"36","author":"Yuan","year":"2025","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.jaad.2025.09.055_bib15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00403-024-03717-3","article-title":"Short-term efficacy and safety of upadacitinib combined with 308 excimer light versus upadacitinib alone and 308 excimer light alone in patients with progressing facial vitiligo","volume":"317","author":"Zhang","year":"2025","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.jaad.2025.09.055_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cpt.3538","article-title":"Efficacy and safety of janus kinase inhibitors in patients with vitiligo: a systematic review and meta-analysis","volume":"117","author":"Huang","year":"2025","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2025.09.055_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/medicina61010054","article-title":"Serum lipids alterations in patients under systemic JAK inhibitors treatments in dermatology: clinical aspects and management","volume":"61","author":"Paolino","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.jaad.2025.09.055_bib18","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2397477","article-title":"Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis","volume":"35","author":"Chen","year":"2024","journal-title":"J Dermatolog Treat"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225028750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225028750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T19:45:27Z","timestamp":1765136727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225028750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":18,"alternative-id":["S0190962225028750"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.09.055","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness and safety of oral Janus kinase inhibitor in vitiligo: A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.09.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}